CytomX Therapeutics, Inc. (CTMX): Price and Financial Metrics
CTMX Price/Volume Stats
| Current price | $0.63 | 52-week high | $5.85 |
| Prev. close | $0.62 | 52-week low | $0.56 |
| Day low | $0.59 | Volume | 865,600 |
| Day high | $0.63 | Avg. volume | 1,842,464 |
| 50-day MA | $0.74 | Dividend yield | N/A |
| 200-day MA | $1.07 | Market Cap | 50.32M |
CTMX Stock Price Chart Interactive Chart >
CytomX Therapeutics, Inc. (CTMX) Company Bio
CytomX Therapeutics develops a novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology. The company was founded in 2008 and is based in San Francisco, California.
CTMX Price Returns
| 1-mo | -6.69% |
| 3-mo | -41.12% |
| 6-mo | -46.61% |
| 1-year | N/A |
| 3-year | -77.26% |
| 5-year | -90.60% |
| YTD | -38.83% |
| 2024 | -33.55% |
| 2023 | -3.13% |
| 2022 | -63.05% |
| 2021 | -33.89% |
| 2020 | -21.18% |
Continue Researching CTMX
Want to do more research on CytomX Therapeutics Inc's stock and its price? Try the links below:CytomX Therapeutics Inc (CTMX) Stock Price | Nasdaq
CytomX Therapeutics Inc (CTMX) Stock Quote, History and News - Yahoo Finance
CytomX Therapeutics Inc (CTMX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...